Skip to main content
Premium Trial:

Request an Annual Quote

Raynard Kington, Guy Van Meter

Raynard Kington will step into the role of acting director of the National Institutes of Health on Friday, Oct. 31, after the departure of Elias Zerhouni, who announced in September that he plans to leave his post.
Zerhouni confirmed this week that he has tapped Kington to take over the post until a new director is appointed, which will happen sometime after the next administration settles into the White House.
Kington has served as Zerhouni’s deputy since 2003, and before that he was associate director of NIH for behavioral and social sciences research. He has also served as acting director of the National Institute on Alcohol Abuse and Alcoholism, and he worked at the National Center for Health Statistics.
Before his arrival at NIH, Kington was a senior scientist at the Rand Corporation, where he was co-director of the Drew/RAND Center on Health and Aging.

Guy Van Meter has joined Adimab as senior director, head of business development, the company announced last week.
Van Meter joins Adimab from Pfizer where he was involved in new business initiatives around RNAi therapeutics and regenerative medicine for Pfizer’s Biotherapeutics and Bioinnovation Center. Before that he was at Dyax where he also worked in business development.
Based in Lebanon, NH, Adimab is developing yeast-based antibodies.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.